Lack of apoE causes alteration of cytokines expression in young mice liver

Molecular Biology Reports

Volumn 37, Issue 4, 2010, Pages 2049-2054

  Yin, Miao ^a   Zhang, Liang ^a   Sun, Xiao Ming ^a   Mao, Liu Feng ^a   Pan, Jie ^a  

^a SHANDONG NORMAL UNIVERSITY   (China)

Author keywords

Apolipoprotein E; Cytokine; Liver

Indexed keywords

APOLIPOPROTEIN E; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; I KAPPA B ALPHA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR RELA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOREGULATION; INFLAMMATION; LIPID METABOLISM; LIVER DYSFUNCTION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WILD TYPE; AGING; ANIMAL; BLOOD; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; IMMUNOLOGY; LIVER; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

MUS;

AGING; ANIMALS; APOLIPOPROTEINS E; CYTOKINES; GENE EXPRESSION REGULATION; GENOTYPE; LIVER; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 77953146996     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9660-x     Document Type: Article

References (17)

1. Pepe MG, Curtiss LK (1986) Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. J Immunol 136:3716-3723
2. Kelly ME, Clay MA, Mistry MJ, Hsieh-Li HM, Harmony JA (1994) Apolipoprotein E inhibition of proliferation of mitogenactivated T lymphocytes: Production of interleukin 2 with reduced biological activity. Cell Immunol 159:124-139. doi: 10.1006/cimm.1994.1302 (Pubitemid 24381044)
3. Roselaar SE, Daugherty A (1998) Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res 39:1740-1743
4. de Bont N, Netea MG, Demacker PN, Kullberg BJ, van der Meer JW, Stalenhoef AF (2000) Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur J Clin Invest 30:818-822. doi:10.1046/j.1365-2362.2000.00715.x
5. Ali K, Middleton M, Pure E, Rader DJ (2005) Apolipoprotein E suppresses the type I inflammatory response in vivo. Circ Res 97:922-927. doi:10.1161/01.RES.0000187467.67684.43 (Pubitemid 41552678)
6. Xiao N, Yin M, Zhang L, Qu X, Du H, Sun X, Mao L, Ren G, Zhang C, Geng Y, An L, Pan J (2009) Tumor necrosis factoralpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice. Mol Genet Metab 96:239-244. doi:10.1016/j.ymgme.2008.11.166
7. Haghighat A, Weiss D, Whalin MK, Cowan DP, Taylor WR (2007) Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice. Circulation 115:2049-2054. doi:10.1161/CIRCULATIONAHA.106.665570 (Pubitemid 46625956)
8. Ditiatkovski M, Toh BH, Bobik A (2006) GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice. Arterioscl Throm Vas 26:2337-2344. doi:10.1161/01.ATV. 0000238357.60338.90 (Pubitemid 44465731)
9. Ye HY, Yin M, Shang YJ, Dai XD, Zhang SQ, Jing W, Du HQ, Zhang L, Pan J (2008) Differential expressions of lipid metabolism related genes in the liver of young apoE knockout mice. Sheng Li Xue Bao 60:51-58
10. Fan CY, Pan J, Usuda N, Yeldandi AV, Rao MS, Reddy JK (1998) Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism. J Biol Chem 273:15639-15645. doi: 10.1074/jbc.273.25.15639 (Pubitemid 28298179)
11. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J Lipid Res 45:1169-1196. doi: 10.1194/jlr.R300019-JLR200 (Pubitemid 38802622)
12. Delerive P, Fruchart JC, Staels B (2001) Peroxisome proliferatoractivated receptors in inflammation control. J Endocrinol 169:453-459. doi:10.1677/joe.0.1690453 (Pubitemid 32536978)
13. Barbier O, Torra IP, Duguay Y, Blanquart C, Fruchart JC, Glineur C, Staels B (2002) Pleiotropic actions of peroxisome proliferatoractivated receptors in lipid metabolism and atherosclerosis. Arterioscl Throm Vas 22:717-726. doi:10.1161/01.ATV.0000015598. 86369.04
14. Youssef J, Badr M (2004) Role of peroxisome proliferator-activated receptors in inflammation control. J Biomed Biotechnol 2004:156-166. doi:10.1155/S1110724304308065 (Pubitemid 39287736)
15. Lehrke M, Millington SC, Lefterova M, Cumaranatunge RG, Szapary P, Wilensky R, Rader DJ, Lazar MA, Reilly MP (2007) CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. J Am Coll Cardiol 49:442-449. doi:10.1016/j.jacc.2006.09.034 (Pubitemid 46135882)
16. Matloubian M, David A, Engel S, Ryan JE, Cyster JG (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1:298-304. doi:10.1038/79738
17. Fan J, Heller NM, Gorospe M, Atasoy U, Stellato C (2005) The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy. Eur Respir J 26:933-947. doi:10.1183/09031936.05.00120204 (Pubitemid 41632053)